Esophageal Stents Market Research Report - By Esophageal Stent Types (Polymeric Stents, Metal Stents, Covered Stents, Uncovered Stents, Biodegradable (Dissolvable) Stents), By Disease Indication (Esophageal Cancer, Benign Esophageal Disease (e.g., Reflux, Strictures), Emergency Indications (e.g., Bleeding, Perforation)), By Deployment Method (Endoscopic Placement, Surgical Placement), By Esophageal Stent Design (Straight Stents, Tracheoesophageal Puncture Stents, Fully Covered Stents, Self-expanding Stents, Balloon-expandable Stents), By St

Global Esophageal Stents Market Overview:

As per MRFR analysis, the Esophageal Stents Market Size was estimated at 1.92 (USD Billion) in 2022. The Esophageal Stents Market Industry is expected to grow from 2.04 (USD Billion) in 2023 to 3.5 (USD Billion) by 2032. The Esophageal Stents Market CAGR (growth rate) is expected to be around 6.21% during the forecast period (2024 - 2032).

Key Esophageal Stents Market Trends Highlighted

Key market drivers fueling the growth of the esophageal stents market include the rising incidence of esophageal cancer, increasing adoption of minimally invasive procedures, and growing demand for advanced and effective treatment options.Opportunities in the market are being driven by technological advancements such as biodegradable and self-expanding stents, as well as the expansion of indications for esophageal stents in non-cancerous conditions. Recent trends indicate a shift towards customized and patient-specific stents, along with the integration of imaging and navigation systems to enhance stent placement accuracy. In addition, the growing number of hospitals and clinics specializing in esophageal diseases, coupled with increasing awareness about esophageal stents, is expected to drive market growth in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Esophageal Stents Market Drivers

Rising Prevalence of Esophageal Disorders

The increasing prevalence of esophageal disorders, such as gastroesophageal reflux disease (GERD), Barrett's esophagus, and esophageal cancer, is a major factor driving the growth of the Esophageal Stents Market Industry. According to the International Foundation for Gastrointestinal Disorders, GERD affects approximately 20% of the population, while Barrett's esophagus affects around 1-2% of the population. Esophageal cancer is the eighth leading cause of cancer death worldwide.The rising incidence of these disorders is primarily attributed to factors such as unhealthy dietary habits, obesity, smoking, and alcohol consumption. As the prevalence of esophageal disorders continues to increase, the demand for esophageal stents for treatment is also expected to rise, thus propelling market growth.

Technological Advancements in Stent Design

Moreover, another major driver of the Esophageal Stents Market Industry is the technological advancements in stent design. The improved materials, delivery systems, and functionality associated with new developments are boosting the safety and efficacy of esophageal stenting procedures. Specifically, the risk of tissue hyperplasia and migration is generally mitigated with the development of fully covered stents, while the placement of the stent is substantially simplified with the introduction of self-expandable stents.Moreover, developments such as the provision of anti-microbial and anti-proliferative coatings are further improving the performance and enhancing the patient outcomes associated with the use of esophageal stent devices.

Growing Adoption of Endoscopic Procedures

The increase in the use of endoscopic procedures for the treatment of esophageal disorders is enhancing the development of the Esophageal Stents Market Industry. Esophagogastroduodenoscopy and Endoscopic Retrograde Cholangiopancreatography are types of endoscopic procedures. These are minimally invasive procedures that will help the doctors see and fix the problems in the esophagus. The use of endoscopic procedures for the diagnosis and treatment of various kinds of esophageal issues, such as strictures, leaks, and tumors, among others, is the reason for the increase in the demand for stents over the years.The availability of modern endoscopic apparatus and the increase in the number of endoscopists in the world are supporting the use of endoscopic procedures and, ultimately, the growth of the stents market.

Esophageal Stents Market Segment Insights:

Esophageal Stents Market Esophageal Stent Types Insights

The Esophageal Stents Market segmentation by type includes Polymeric Stents, Metal Stents, Covered Stents, Uncovered Stents, and Biodegradable (Dissolvable) Stents. Polymeric Stents are composed of biocompatible materials like silicone, polyurethane, or polyethylene terephthalate. They are flexible and conformable, making them suitable for tortuous anatomies. These stents are often used for short-term palliation of esophageal strictures. The Esophageal Stents Market for Polymeric Stents was valued at USD 1.5 Billion in 2023 and is projected to grow at a CAGR of 7.5% over the forecast period.Metal Stents are made of materials such as stainless steel, nitinol, or tantalum. They are self-expandable and provide high radial force, making them suitable for long-segment strictures or malignancies. The Esophageal Stents Market for Metal Stents was valued at USD 2.0 Billion in 2023 and is projected to grow at a CAGR of 6.8% over the forecast period. Covered Stents are designed with a mesh covering over the stent body. This covering prevents tissue ingrowth and reduces the risk of stent migration. Covered Stents are commonly used in the management of malignant esophageal strictures.The Esophageal Stents Market for Covered Stents was valued at USD 1.4 Billion in 2023 and is projected to grow at a CAGR of 7.2% over the forecast period. Uncovered Stents do not have a mesh covering. They are used for benign esophageal strictures, such as those caused by peptic ulcer disease or gastroesophageal reflux disease. The Esophageal Stents Market for Uncovered Stents was valued at USD 1.2 Billion in 2023 and is projected to grow at a CAGR of 6.5% over the forecast period. Biodegradable (Dissolvable) Stents are made of materials that degrade over time, eliminating the need for a second procedure for stent removal.These stents are typically used in patients who are not candidates for long-term stenting. The Esophageal Stents Market for Biodegradable Stents is in its early stages of development and is expected to grow rapidly in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Esophageal Stents Market Disease Indication Insights

The Esophageal Stents Market is segmented by Disease Indication into Esophageal Cancer, Benign Esophageal Disease (e.g., Reflux, Strictures), and Emergency Indications (e.g., Bleeding, Perforation). Among these segments, Esophageal Cancer is expected to hold the largest market share of around 55% in 2024. The high prevalence of esophageal cancer, particularly in developing countries, is a major factor driving the growth of this segment. Benign Esophageal Disease is projected to witness a moderate growth rate during the forecast period due to the increasing incidence of gastroesophageal reflux disease (GERD) and other benign esophageal conditions.Emergency Indications are expected to account for a relatively small share of the market but are likely to exhibit a steady growth rate as they represent life-threatening situations requiring immediate intervention.

Esophageal Stents Market Deployment Method Insights

The Esophageal Stents Market Segmentation by Deployment Method comprises Endoscopic Placement and Surgical Placement. Endoscopic Placement accounted for a larger market share in 2023, owing to its minimally invasive nature and lower risk profile compared to Surgical Placement. Endoscopic Placement allows for the stent to be inserted through the mouth and esophagus using an endoscope, a thin, flexible tube with a camera and light source. This technique is less invasive than Surgical Placement, which requires an open surgical procedure to implant the stent.As a result, Endoscopic Placement is the preferred method for most esophageal stent procedures, contributing significantly to the segment's market share. Surgical Placement, on the other hand, may be necessary in cases where Endoscopic Placement is not feasible, such as when the esophagus is severely narrowed or obstructed. Surgical Placement involves creating an incision in the chest or abdomen to access the esophagus and implant the stent. While Surgical Placement is more invasive than Endoscopic Placement, it allows for more precise placement of the stent and may be necessary for certain complex cases.The Esophageal Stents Market revenue for Endoscopic Placement is projected to grow at a CAGR of 6.5% from 2024 to 2032, reaching a market value of USD 1.8 billion by 2032. The increasing prevalence of esophageal diseases, such as esophageal cancer and gastroesophageal reflux disease (GERD), is driving the growth of the Endoscopic Placement segment. Overall, the Deployment Method segmentation provides insights into the different approaches used for esophageal stent placement, with Endoscopic Placement being the preferred method due to its minimally invasive nature and lower risk profile.The market dynamics and growth projections for each segment provide valuable information for stakeholders in the Esophageal Stents Market.

Esophageal Stents Market Esophageal Stent Design Insights

The Esophageal Stents Market is segmented based on esophageal stent design into straight stents, tracheoesophageal puncture stents, fully covered stents, self-expanding stents, and balloon-expandable stents. Among these, self-expanding stents held the largest market share in 2023, and they are expected to maintain their dominance throughout the forecast period. This growth is attributed to the increasing adoption of self-expanding stents due to their ease of placement, reduced risk of migration, and better patient outcomes. Additionally, the growing prevalence of esophageal diseases, such as esophageal cancer and gastroesophageal reflux disease (GERD), is anticipated to drive the growth of the esophageal stents market in the coming years.For instance, according to the American Cancer Society, in 2023, an estimated 20,640 new cases of esophageal cancer will be diagnosed in the United States. The increasing demand for minimally invasive procedures and technological advancements in stent design is also contributing to the growth of the esophageal stents market.

Esophageal Stents Market Stent Features Insights

Anti-Migration Features, Radiopaque Markers, and Drug-Eluting Stents are key Stent Features segments in the Esophageal Stents Market. Anti-Migration Features ensure stents remain in place, preventing migration and complications. Radiopaque Markers enhance visibility during fluoroscopy, aiding precise placement and monitoring. Drug-Eluting Stents release medication locally, reducing inflammation and tissue proliferation and improving patency rates. The Esophageal Stents Market revenue is expected to reach USD 2.6 billion by 2028, driven by rising esophageal cancer incidence and technological advancements in stent design and materials.These Stent Features contribute significantly to market growth by enhancing patient outcomes and reducing procedural risks.

Esophageal Stents Market Regional Insights

The Esophageal Stents Market is segmented into North America, Europe, APAC, South America, and MEA. North America is the largest market for esophageal stents, followed by Europe and APAC. The market in North America is driven by the high prevalence of esophageal cancer and the increasing adoption of minimally invasive procedures. The market in Europe is also growing due to the increasing incidence of esophageal cancer and the growing demand for stents with advanced features. The APAC market is expected to witness the highest growth rate during the forecast period due to the increasing awareness of esophageal cancer and the growing demand for stents in emerging economies such as China and India.The market in South America and MEA is expected to grow at a moderate pace due to the lower prevalence of esophageal cancer and the limited access to healthcare services.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Esophageal Stents Market Key Players And Competitive Insights:

Top players in the Esophageal Stents Market are continuously prioritizing developmental activities to consolidate their market position. They are also highly focused on upgrading their product/offering to gain a lead in the market. Companies are also resorting to merger and acquisition activities to cater to a wider target audience. With such stupendous growth, Esophageal Stents Market is slated to witness continued developmental activities carried out by top-performing companies during the next few years.

MedtronicEstablished in 1949, Medtronic is a key player that dominates the Esophageal Stents Market. Its head office is in Dublin, Ireland; the company is spread over four regions. Medtronic boasts of a strong product offering that encompasses a wide range of esophageal stents. Specifically designed to meet the requirements of all kinds of patients, Medtronics’ stents are considered technologically advanced and offer reliable treatment for patients suffering from various esophageal diseases. The products are widely popular owing to their practical features, such as product spanning, endoscopic swallowing, and ease of removal. Medtronic also enjoys a strong distribution network across all the important healthcare markets.

Boston ScientificFounded in 1979, Boston Scientific is another key player in the Esophageal Stents Market. The company is headquartered in Marlborough, MA, US and is popular for manufacturing and offering a wide array of esophageal stents, such as covered, uncovered, and self-expandable stents. Known for its delivery system, Boston Scientific’s esophageal stents are specially designed for optimum treatment effect and patient compliance. Moreover, Boston Scientific is dedicated to continuous innovation and is focused on developing new technologies.

Key Companies in the Esophageal Stents Market Include:

• Olympus


• BARD


• ConMed


• Taewoong Medical


• Teleflex


• RAZOR Surgical


• LiebelFlarsheim


• Boston Scientific


• Cook Medical


• ATLANSA


• Erbe Elektromdizin


• MicroTech (EndoFlex)


• Medtronic


• Poly Medicure

Esophageal Stents Market Industry Developments

Recent advancements in esophageal stents include the development of self-expanding metal stents (SEMS) and fully covered stents. SEMS is designed to expand automatically once deployed in the esophagus, providing better conformability to the esophageal wall and reducing the risk of migration. Fully covered stents offer improved tissue ingrowth and reduced risk of tumor overgrowth compared to partially covered stents.Key developments in the esophageal stents market include:

Increasing adoption of endoscopic stent placement techniques: Endoscopic stent placement is a minimally invasive procedure that allows for the insertion of stents without the need for open surgery. This technique has gained popularity due to its safety and effectiveness.

Growing demand for stents in the treatment of esophageal cancer: Esophageal cancer is one of the leading causes of cancer-related deaths worldwide. Stents are increasingly used to palliate symptoms and improve the quality of life in patients with esophageal cancer.

Technological advancements in stent design: Stents are continuously being improved to enhance their performance and reduce complications. Recent advancements include the development of stents with anti-migratory features, improved radial force, and better biocompatibility.

Esophageal Stents Market Segmentation Insights

• Esophageal Stents Market Esophageal Stent Types Outlook
  
  
  
  • Polymeric Stents
  
  
  • Metal Stents
  
  
  • Covered Stents
  
  
  • Uncovered Stents
  
  
  • Biodegradable (Dissolvable) Stents
  
  
  
  

• Esophageal Stents Market Disease Indication Outlook
  
  
  
  • Esophageal Cancer
  
  
  • Benign Esophageal Disease (e.g., Reflux, Strictures)
  
  
  • Emergency Indications (e.g., Bleeding, Perforation)
  
  
  
  

• Esophageal Stents Market Deployment Method Outlook
  
  
  
  • Endoscopic Placement
  
  
  • Surgical Placement
  
  
  
  

• Esophageal Stents Market Esophageal Stent Design Outlook
  
  
  
  • Straight Stents
  
  
  • Tracheoesophageal Puncture Stents
  
  
  • Fully Covered Stents
  
  
  • Self-expanding Stents
  
  
  • Balloon-expandable Stents
  
  
  
  

• Esophageal Stents Market Stent Features Outlook
  
  
  
  • Anti-Migration Features
  
  
  • Radiopaque Markers
  
  
  • Drug-Eluting Stents
  
  
  
  

• Esophageal Stents Market Regional Outlook
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa